This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Johns Hopkins University. Active years: 2015-2021.
Location History:
- Towson, MD (US) (2015)
- Baltimore, MD (US) (2021)
Company Filing History:
Years Active: 2015-2021
Title: Innovations and Contributions of Inventor Mohammad O Hoque
Introduction
Mohammad O Hoque is a notable inventor based in Towson, MD (US), recognized for his significant contributions to the field of cancer research. With a total of three patents to his name, he has made strides in developing methods for the detection and treatment of urothelial cancer.
Latest Patents
One of his latest patents focuses on "Urothelial cancer and methods of detection and targeted therapy." This invention provides methods for detecting a cellular proliferative disorder, such as urothelial cancer, by assessing the methylation status of the GULP1 promoter in a nucleic acid sample. The methods are valuable for diagnostic, prognostic, and therapeutic regimen predictions. Another significant patent involves "Pharmaceutical agents targeting cancer stem cells." This patent outlines methods for preventing or treating subjects with cancer by identifying pharmaceutical agents that target cancer stem cells (CSCs). The methods include administering effective amounts of a COX2 inhibitor and a YAP1 inhibitor, along with strategies to enhance chemotherapeutic responses in cancer patients.
Career Highlights
Mohammad O Hoque is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations in cancer therapies. His work is characterized by a commitment to improving patient outcomes through scientific discovery.
Collaborations
He collaborates with esteemed colleagues, including Masamichi Hayashi and Elisa Guida, to further enhance the impact of his research in the medical field.
Conclusion
Mohammad O Hoque's innovative work in cancer detection and treatment exemplifies the vital role of inventors in advancing medical science. His contributions are paving the way for improved diagnostic and therapeutic strategies in oncology.